Internal Medicine, Medical Oncology · Lansing, MI
NPI
1992226575
Since 2017
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1215 E Michigan Ave
Lansing, MI, 48912
Phone (517) 364-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
775 services
Medicare patients, 2024
121
Average age 74
Drug cost, 2024
$2.7M
840 prescriptions
Company payments, 2025
$37K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fawzi Abu Rous was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 128 times for 41 patients. In total Fawzi Abu Rous billed 775 services in 22 codes, and Medicare paid $50K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 128 | 41 | $13.12 | $1,680 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 100 | 36 | $12.86 | $1,286 |
| 99215 Office E&M - Established | Office | 91 | 27 | $114.34 | $10K |
| 99215 Office E&M - Established | Facility | 76 | 31 | $109.59 | $8,329 |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 21 | $61.89 | $3,837 |
| 99214 Office E&M - Established | Office | 34 | 25 | $74.69 | $2,539 |
| 99214 Office E&M - Established | Facility | 26 | 20 | $74.89 | $1,947 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $105.20 | $1,894 |
| 99205 Office E&M - New | Facility | 15 | 15 | $146.65 | $2,200 |
| 99238 Hospital Discharge Management | Facility | 12 | 12 | $59.28 | $711 |
| 99205 Office E&M - New | Office | 12 | 12 | $136.99 | $1,644 |
By year: 2023 $11K for 98 services; 2024 $50K for 775 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fawzi Abu Rous prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 94 prescriptions and refills. In total Fawzi Abu Rous wrote 840 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 94 | 94 | 14 | $1.4M |
| Dexamethasone Generic | 84 | 84 | 33 | $313 |
| Olanzapine Generic | 68 | 68 | 28 | $127 |
| Eliquis Apixaban | 48 | 67 | 15 | $38K |
| Ondansetron Odt Ondansetron | 38 | 39 | 32 | $728 |
| Tabrecta Capmatinib Hydrochloride | 26 | 26 | Under 11 | $528K |
| Prochlorperazine Maleate Generic | 25 | 25 | 20 | $594 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 25 | 25 | Under 11 | $837 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 25 | 15 | $244 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 19 | 19 | 12 | $209 |
| Prednisone Generic | 19 | 25 | 12 | $55.11 |
| Loperamide Loperamide Hcl | 19 | 19 | Under 11 | $332 |
| Mirtazapine Generic | 17 | 23 | Under 11 | $130 |
| Folic Acid Generic | 16 | 48 | Under 11 | $107 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $205 |
Brand drugs: - claims; generic drugs: 550 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fawzi Abu Rous $37K ($37K in general payments such as food, travel and fees) from 12 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.